Showing results (231-240 of 282) with videos related to
Sort By:
Pageof 29
Cancer Chemotherapy and Pharmacology|January 1, 1992
Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesionsM Monden, M Sakon, M Gotoh, et al.Antimicrobial Agents and Chemotherapy|November 6, 2019
Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary ExacerbationJames M Kidd, Colleen M Sakon, Louise-Marie Oleksiuk, et al.Cell Transplantation|January 6, 2001
Role of the liver in alloimmune response following inoculation of donor spleen cellsL He, K Dono, M Gotoh, et al.Cancer Letters|February 7, 2001
Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancersT Aihara, Y Fujiwara, Y Miyake, et al.Cell Transplantation|August 26, 1998
Pretreatment of crude pancreatic islets with mitomycin C (MMC) prolongs islet graft survival in a xenogeneic rat-to-mouse modelT Grochowiecki, M Gotoh, K Dono, et al.Digestive Diseases and Sciences|August 29, 2000
Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinomaA Miyamoto, Y Fujiwara, M Sakon, et al.Pathology, Research and Practice|March 23, 2001
Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinomaY Ito, T Takeda, Y Sasaki, et al.Archives of Surgery (Chicago, Ill. : 1960)|December 15, 2000
Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curvesM Sakon, K Umeshita, H Nagano, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 20, 2017
A retrospective analysis of the clinical effects of neoadjuvant combination therapy with full-dose gemcitabine and radiation therapy in patients with biliary tract cancerS Kobayashi, A Tomokuni, K Gotoh, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1996
[Locoregional injection of OK-432/fibrinogen/thrombin for unresectable metastatic liver tumors]T Yoshida, H Osato, M Sakon, et al.Pageof 29